Evidence map›Paper›PMID 28424681›Full record

ArticleFrontiers in immunology2017

The Spontaneous Autoimmune Neuromyopathy in ICOSL

Claire Briet, Gwladys Bourdenet, Ute C Rogner, Chantal Becourt, Isabelle Tardivel, Laurent Drouot, Christophe Arnoult, Jean-Claude do Rego, Nicolas Prevot, Charbel Massaad and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Claire BrietINSERM U1016, Cochin Institute, Paris Descartes University, Sorbonne Paris Cité, Paris, France.
Gwladys BourdenetNormandie Université, UNIROUEN, INSERM, U1234, Rouen University Hospital, Department of Immunology, Rouen, France.
Ute C RognerINSERM U1016, Cochin Institute, Paris, France.
Chantal BecourtINSERM U1016, Cochin Institute, Paris, France.
Isabelle TardivelINSERM U1016, Cochin Institute, Paris, France.
Laurent DrouotNormandie Université, UNIROUEN, INSERM, U1234, Rouen University Hospital, Department of Immunology, Rouen, France.
Christophe ArnoultNormandie Université, UNIROUEN, CNRS, UMR 6270, Rouen, France.
Jean-Claude do RegoNormandie Université, UNIROUEN, SCAC, INSERM, U1234, Rouen, France.
Nicolas PrevotDevelopmental Immunology, Department of Paediatrics, and the Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Charbel MassaadINSERM UMR S1124, Paris Descartes University, Paris, France.
Olivier BoyerNormandie Université, UNIROUEN, INSERM, U1234, Rouen University Hospital, Department of Immunology, Rouen, France.
Christian BoitardINSERM U1016, Cochin Institute, Paris Descartes University, Sorbonne Paris Cité, Paris, France.
Inserm · FRInstitut Cochin · FRUniversité de Rouen Normandie · FRNormandie Université · FRUniversité Paris Cité · FRUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abrogation of ICOS/ICOS ligand (ICOSL) costimulation prevents the onset of diabetes in the non-obese diabetic (NOD) mouse but, remarkably, yields to the development of a spontaneous autoimmune neuromyopathy. At the pathological level, ICOSL

Indexed as

autoimmunitycostimulationICOSICOSLmyopathyneuropathytype 1 diabetes

Identifiers

PMID28424681
PMCPMC5371727
OpenAlexW2603669322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.